Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-PD-1 +/- DC-CIK in advanced solid tumors
NCT03190811Phase 2Completed
- Sponsor
- Capital Medical University
- Start
- Sep 2016
- Primary completion
- Dec 2022
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of dendritic cell vaccine + cytokine-induced killer cells in solid tumor, sponsored by Capital Medical University. Started Sep 2016; status: completed.
02
Drugs
dendritic cell vaccine + cytokine-induced killer cells
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03190811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03190811.